These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33210016)

  • 21. Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study.
    McNeil JJ; Woods RL; Nelson MR; Murray AM; Reid CM; Kirpach B; Storey E; Shah RC; Wolfe RS; Tonkin AM; Newman AB; Williamson JD; Lockery JE; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Trevaks RE; Orchard SG; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Grimm RH;
    J Gerontol A Biol Sci Med Sci; 2017 Oct; 72(11):1586-1593. PubMed ID: 28329340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of aspirin use with age-related macular degeneration.
    Liew G; Mitchell P; Wong TY; Rochtchina E; Wang JJ
    JAMA Intern Med; 2013 Feb; 173(4):258-64. PubMed ID: 23337937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reticular Pseudodrusen and Their Association with Age-Related Macular Degeneration: The Melbourne Collaborative Cohort Study.
    Finger RP; Chong E; McGuinness MB; Robman LD; Aung KZ; Giles G; Baird PN; Guymer RH
    Ophthalmology; 2016 Mar; 123(3):599-608. PubMed ID: 26681391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progression of Age-Related Macular Degeneration Among Individuals Homozygous for Risk Alleles on Chromosome 1 (CFH-CFHR5) or Chromosome 10 (ARMS2/HTRA1) or Both.
    Schmitz-Valckenberg S; Fleckenstein M; Zouache MA; Pfau M; Pappas C; Hageman JL; Agrón E; Malley C; Keenan TDL; Chew EY; Hageman GS
    JAMA Ophthalmol; 2022 Mar; 140(3):252-260. PubMed ID: 35113155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An association of neovascular age-related macular degeneration with polymorphisms of CFH, ARMS2, HTRA1 and C3 genes in Czech population.
    Matušková V; Zeman T; Ewerlingová L; Hlinomazová Z; Souček J; Vlková E; Goswami N; Balcar VJ; Šerý O
    Acta Ophthalmol; 2020 Sep; 98(6):e691-e699. PubMed ID: 31970928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for progression of age-related macular degeneration.
    Heesterbeek TJ; Lorés-Motta L; Hoyng CB; Lechanteur YTE; den Hollander AI
    Ophthalmic Physiol Opt; 2020 Mar; 40(2):140-170. PubMed ID: 32100327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration.
    Yu Y; Reynolds R; Fagerness J; Rosner B; Daly MJ; Seddon JM
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4663-70. PubMed ID: 21447678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a Genotype Assay for Age-Related Macular Degeneration: The EYE-RISK Consortium.
    de Breuk A; Acar IE; Kersten E; Schijvenaars MMVAP; Colijn JM; Haer-Wigman L; Bakker B; de Jong S; Meester-Smoor MA; Verzijden T; Missotten TOAR; Monés J; Biarnés M; Pauleikhoff D; Hense HW; Silva R; Nunes S; Melo JB; Fauser S; Hoyng CB; Ueffing M; Coenen MJH; Klaver CCW; den Hollander AI;
    Ophthalmology; 2021 Nov; 128(11):1604-1617. PubMed ID: 32717343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of Age-Related Macular Degeneration in a Multi-Ethnic United States Population: The Multi-Ethnic Study of Atherosclerosis.
    Fisher DE; Klein BE; Wong TY; Rotter JI; Li X; Shrager S; Burke GL; Klein R; Cotch MF
    Ophthalmology; 2016 Jun; 123(6):1297-308. PubMed ID: 26896123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Prediction for Progression of Macular Degeneration: 10 Common and Rare Genetic Variants, Demographic, Environmental, and Macular Covariates.
    Seddon JM; Silver RE; Kwong M; Rosner B
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2192-202. PubMed ID: 25655794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health Characteristics and Aspirin Use in Participants at the Baseline of the ASPirin in Reducing Events in the Elderly - eXTension (ASPREE-XT) Observational Study.
    Ernst ME; Broder JC; Wolfe R; Woods RL; Nelson MR; Ryan J; Shah RC; Orchard SG; Chan AT; Espinoza SE; Wilson M; Kirpach B; Reid CM; McNeil JJ; Williamson JD; Murray AM;
    Contemp Clin Trials; 2023 Jul; 130():107231. PubMed ID: 37196887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ARMS2 A69S Polymorphism Is Associated with Delayed Rod-Mediated Dark Adaptation in Eyes at Risk for Incident Age-Related Macular Degeneration.
    Mullins RF; McGwin G; Searcey K; Clark ME; Kennedy EL; Curcio CA; Stone EM; Owsley C
    Ophthalmology; 2019 Apr; 126(4):591-600. PubMed ID: 30389424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-related macular degeneration in Portugal: prevalence and risk factors in a coastal and an inland town. The Coimbra Eye Study - Report 2.
    Cachulo Mda L; Laíns I; Lobo C; Figueira J; Ribeiro L; Marques JP; Costa J; Vieira A; Rodrigues J; Alves D; Nunes S; Costa M; Rodrigues V; Cunha-Vaz J; Delcourt C; Silva R
    Acta Ophthalmol; 2016 Sep; 94(6):e442-53. PubMed ID: 26806024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38.
    Chew EY; Klein ML; Clemons TE; Agrón E; Ratnapriya R; Edwards AO; Fritsche LG; Swaroop A; Abecasis GR;
    Ophthalmology; 2014 Nov; 121(11):2173-80. PubMed ID: 24974817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term use of aspirin and age-related macular degeneration.
    Klein BE; Howard KP; Gangnon RE; Dreyer JO; Lee KE; Klein R
    JAMA; 2012 Dec; 308(23):2469-78. PubMed ID: 23288416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence to the Mediterranean Diet and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2.
    Keenan TD; Agrón E; Mares J; Clemons TE; van Asten F; Swaroop A; Chew EY;
    Ophthalmology; 2020 Nov; 127(11):1515-1528. PubMed ID: 32348832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated high-density lipoprotein cholesterol and age-related macular degeneration: the Alienor study.
    Cougnard-Grégoire A; Delyfer MN; Korobelnik JF; Rougier MB; Le Goff M; Dartigues JF; Barberger-Gateau P; Delcourt C
    PLoS One; 2014; 9(3):e90973. PubMed ID: 24608419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomised trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration.
    Sammons E; Bowman L; Stevens W; Buck G; Wallendszus K; Hammami I; Parish S; Armitage J;
    Contemp Clin Trials Commun; 2023 Oct; 35():101184. PubMed ID: 37745288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration.
    Guymer RH; Baird PN; Varsamidis M; Busija L; Dimitrov PN; Aung KZ; Makeyeva GA; Richardson AJ; Lim L; Robman LD
    PLoS One; 2013; 8(12):e83759. PubMed ID: 24391822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship of atherosclerosis to the 10-year cumulative incidence of age-related macular degeneration: the Beaver Dam studies.
    Klein R; Cruickshanks KJ; Myers CE; Sivakumaran TA; Iyengar SK; Meuer SM; Schubert CR; Gangnon RE; Klein BE
    Ophthalmology; 2013 May; 120(5):1012-9. PubMed ID: 23399375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.